REV by Relx Group

REV, formerly known as Reed Elsevier Ventures, is the corporate venture capital arm of RELX Group, a global provider of information and analytics. Established in 2000, REV focuses on investing in early and mid-stage companies operating in sectors such as big data, analytics, healthcare information, software, mobile platforms, and business and consumer internet.

Since its inception, REV has invested over $250 million in various companies, including notable investments in Palantir, Healthline, Babbel, and Netli.

REV’s investment strategy emphasizes partnering with companies that leverage data, technology, and analytics to transform their respective markets. The firm operates globally, with a presence in major venture capital hubs such as San Francisco, New York, Boston, Los Angeles, Seattle, London, Berlin, and Tel Aviv.

Through its investments, REV aims to support the growth of innovative companies that are poised to make significant impacts in their industries.